Healthcare-payments software company Waystar seeks about $1 billion in IPO
By Steve Gelsi
Waystar serves about 30,000 clients that represent more than one million providers.
Waystar Holding Corp., a healthcare-payments software company, said Tuesday it plans to raise about $1 billion in its initial public offering.
The Lehi, Utah-based company plans to trade under the symbol WAY on the Nasdaq.
Waystar plans to offer 45 million shares at an estimated price range of $20 to $23 a share in its upcoming initial public offering.
At the midpoint of the range, Waystar's IPO will raise about $967.5 million with underwriters JPMorgan Chase & Co. (JPM), Goldman Sachs Group Inc. (GS) and Barclays PLC (BCS).
With 173.4 million shares outstanding, including shares allotted to underwriters, Waystar's market capitalization will be about $3.7 billion. That's at the midpoint of the estimated price range or $21.50 a share.
Founded in 2000, Waystar is backed by EQT AB (SE:EQT), Canada Pension Plan Investment Board, Bain Capital and Francisco Partners.
The company reported a full-year 2023 net loss of $51.33 million and revenue of $791 million, compared to a 2022 net loss of $51.5 million and revenue of $704.9 million.
Waystar, which came out of the combination of Navicure and ZirMed in 2017, makes claims-management and patient-payment software to help its network of about 30,000 clients, representing more than one million providers.
-Steve Gelsi
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
05-28-24 0801ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
Six Sports Betting and iGaming Stocks Trading at a Discount
-
4 Predictions for Stocks and the Economy for the Second Half of 2024
-
What Broadening Rally? AI Stocks Dominate Again In Q2
-
After Earnings, Is Nike Stock a Buy, a Sell, or Fairly Valued?
-
Worst-Performing Stock ETFs of the Quarter
-
Top-Performing Stock ETFs of the Quarter
-
Q2 In Review and Q3 2024 Market Outlook
-
5 Stocks to Buy for 3Q 2024
-
Industrials: Sector Offers Investment Opportunities as Performance Lags Broader Market
-
Consumer Defensives: Even Amid Macro Pressures, Deals Permeate the Landscape
-
33 Undervalued Stocks
-
Utilities: Can the Stocks Keep the Rally Going?
-
Basic Materials: Following Index Decline, We See Many Long-Term Opportunities
-
Healthcare: Valuations Look Attractive In Most Industries
-
Financial Services: Amid Uncertainties, We See the Most Value In Banks and Credit Services
-
Consumer Cyclicals: Even With Anxiety Over Spending, We See Attractive Valuations